Farther Finance Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History
Bought
Maintained
Sold
Other funds holding RDY
BCAM
NAM
CIM
HCA
AAM
FG
DAS
GI
TWD
Farther Finance Advisors's RDY Position: Q3 2026 in Review
Farther Finance Advisors reduced its Dr. Reddy's Laboratories (RDY) stake by 20% in Q3 2026, selling an estimated $33.6K and leaving 10,882 shares worth $137K. The position accounts for ﹤0.01% of the portfolio, ranked #2600.
Farther Finance Advisors first reported a position in RDY in Q3 2023 and has held it in 13 quarters since. The position peaked at $214K in Q4 2025. 13 funds tracked by Wall St. Rank hold RDY as of Q3 2026.
- Farther Finance Advisors held 10,882 shares of Dr. Reddy's Laboratories worth $137K as of Q3 2026.
- Farther Finance Advisors sold 2,714 Dr. Reddy's Laboratories shares in Q3 2026, an estimated $33.6K.
- Dr. Reddy's Laboratories made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #2600 holding.
- Farther Finance Advisors first reported a position in Dr. Reddy's Laboratories in Q3 2023 and has held it in 13 quarters since.
- Farther Finance Advisors's Dr. Reddy's Laboratories position peaked at $214K in Q4 2025.
- 13 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2026.
Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.